Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Therapy for Drug-resistant Bacterial Infections
NCT07382271Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Modality
- Single Strain Products, Multi-strain Products
01
Overview
Open-label, single-arm trial of personalized phage cocktail in urinary tract infection (UTI), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Pathogen Clearance Rate at Day 7 and Incidence of adverse events up to 5 weeks. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
personalized phage cocktail
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07382271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07382271.